605507.SH
Guobang Pharma Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 15.38
−1.28%Sep 15, 2026, 09:12 UTC
Guobang Pharma's wholly owned subsidiary Zhejiang Guobang Pharmaceutical received an 'A' status from China's CDE for its injectable-grade glyceryl dipalmitate excipient, clearing it for commercial supply to downstream formulation customers.
Source: